133 related articles for article (PubMed ID: 33161121)
1. Fullerene derivatives as dual inhibitors of HIV-1 reverse transcriptase and protease.
Yasuno T; Ohe T; Kataoka H; Hashimoto K; Ishikawa Y; Furukawa K; Tateishi Y; Kobayashi T; Takahashi K; Nakamura S; Mashino T
Bioorg Med Chem Lett; 2021 Jan; 31():127675. PubMed ID: 33161121
[TBL] [Abstract][Full Text] [Related]
2. Novel pyridinium-type fullerene derivatives as multitargeting inhibitors of HIV-1 reverse transcriptase, HIV-1 protease, and HCV NS5B polymerase.
Kobayashi T; Yasuno T; Takahashi K; Nakamura S; Mashino T; Ohe T
Bioorg Med Chem Lett; 2021 Oct; 49():128267. PubMed ID: 34271071
[TBL] [Abstract][Full Text] [Related]
3. Rational design and Structure-Activity relationship of coumarin derivatives effective on HIV-1 protease and partially on HIV-1 reverse transcriptase.
Zhu M; Ma L; Wen J; Dong B; Wang Y; Wang Z; Zhou J; Zhang G; Wang J; Guo Y; Liang C; Cen S; Wang Y
Eur J Med Chem; 2020 Jan; 186():111900. PubMed ID: 31771827
[TBL] [Abstract][Full Text] [Related]
4. Design and biological evaluation of cinnamic and phenylpropionic amide derivatives as novel dual inhibitors of HIV-1 protease and reverse transcriptase.
Zhu M; Shan Q; Ma L; Wen J; Dong B; Zhang G; Wang M; Wang J; Zhou J; Cen S; Wang Y
Eur J Med Chem; 2021 Aug; 220():113498. PubMed ID: 33933756
[TBL] [Abstract][Full Text] [Related]
5. The human immunodeficiency virus-reverse transcriptase inhibition activity of novel pyridine/pyridinium-type fullerene derivatives.
Yasuno T; Ohe T; Takahashi K; Nakamura S; Mashino T
Bioorg Med Chem Lett; 2015 Aug; 25(16):3226-9. PubMed ID: 26081290
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of coumarin derivatives as potential dual-action HIV-1 protease and reverse transcriptase inhibitors.
Olomola TO; Klein R; Mautsa N; Sayed Y; Kaye PT
Bioorg Med Chem; 2013 Apr; 21(7):1964-71. PubMed ID: 23415084
[TBL] [Abstract][Full Text] [Related]
7. Deformation density components analysis of fullerene-based anti-HIV drugs.
Fakhraee S; Souri M
J Mol Model; 2014 Nov; 20(11):2486. PubMed ID: 25388278
[TBL] [Abstract][Full Text] [Related]
8. Tetra-chloro-(bis-(3,5-dimethylpyrazolyl)methane)gold(III) chloride: An HIV-1 reverse transcriptase and protease inhibitor.
Fonteh PN; Keter FK; Meyer D; Guzei IA; Darkwa J
J Inorg Biochem; 2009 Feb; 103(2):190-4. PubMed ID: 19019450
[TBL] [Abstract][Full Text] [Related]
9. [HIV reproduction inhibition by amino acid and dipeptide derivatives of fullerene C60].
Miller GG; Romanova VS; Pokidysheva LN; Titova IV; Kaliberda EN; Rumsh LD; Andreeva OI; Rybalkin NP
Antibiot Khimioter; 2004; 49(12):3-8. PubMed ID: 16050493
[TBL] [Abstract][Full Text] [Related]
10. Characterization of New Cationic N,N-Dimethyl[70]fulleropyrrolidinium Iodide Derivatives as Potent HIV-1 Maturation Inhibitors.
Castro E; Martinez ZS; Seong CS; Cabrera-Espinoza A; Ruiz M; Hernandez Garcia A; Valdez F; Llano M; Echegoyen L
J Med Chem; 2016 Dec; 59(24):10963-10973. PubMed ID: 28002960
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus-reverse transcriptase inhibition and hepatitis C virus RNA-dependent RNA polymerase inhibition activities of fullerene derivatives.
Mashino T; Shimotohno K; Ikegami N; Nishikawa D; Okuda K; Takahashi K; Nakamura S; Mochizuki M
Bioorg Med Chem Lett; 2005 Feb; 15(4):1107-9. PubMed ID: 15686922
[TBL] [Abstract][Full Text] [Related]
12. Molecular Dynamics Simulation Study of the HIV-1 Protease Inhibit ion Using Fullerene and New Fullerene Derivatives of Carbon Nanostructures.
Barzegar A; Naghizadeh E; Zakariazadeh M; Azamat J
Mini Rev Med Chem; 2017; 17(7):633-647. PubMed ID: 27292780
[TBL] [Abstract][Full Text] [Related]
13. Structure based design and evaluation of benzoheterocycle derivatives as potential dual HIV-1 protease and reverse transcriptase inhibitors.
Zhu M; Shan Q; Ma L; Dong B; Wang J; Zhang G; Wang M; Zhou J; Cen S; Wang Y
Eur J Med Chem; 2023 Jan; 246():114981. PubMed ID: 36481598
[TBL] [Abstract][Full Text] [Related]
14. Active site binding modes of dimeric phloroglucinols for HIV-1 reverse transcriptase, protease and integrase.
Gupta P; Kumar R; Garg P; Singh IP
Bioorg Med Chem Lett; 2010 Aug; 20(15):4427-31. PubMed ID: 20594846
[TBL] [Abstract][Full Text] [Related]
15. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
[TBL] [Abstract][Full Text] [Related]
16. Receptor- and ligand-based study of fullerene analogues: comprehensive computational approach including quantum-chemical, QSAR and molecular docking simulations.
Ahmed L; Rasulev B; Turabekova M; Leszczynska D; Leszczynski J
Org Biomol Chem; 2013 Sep; 11(35):5798-808. PubMed ID: 23900343
[TBL] [Abstract][Full Text] [Related]
17. SMILES-based optimal descriptors: QSAR analysis of fullerene-based HIV-1 PR inhibitors by means of balance of correlations.
Toropov AA; Toropova AP; Benfenati E; Leszczynska D; Leszczynski J
J Comput Chem; 2010 Jan; 31(2):381-92. PubMed ID: 19479738
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 protease and RNase H of HIV-1 reverse transcriptase activities by long chain phenols from the sarcotestas of Ginkgo biloba.
Lee JS; Hattori M; Kim J
Planta Med; 2008 Apr; 74(5):532-4. PubMed ID: 18543149
[TBL] [Abstract][Full Text] [Related]
19. New anti-HIV agents and targets.
De Clercq E
Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors.
Chen X; Zhan P; Liu X; Cheng Z; Meng C; Shao S; Pannecouque C; De Clercq E; Liu X
Bioorg Med Chem; 2012 Jun; 20(12):3856-64. PubMed ID: 22591854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]